Recovery of FRI-5 carbapenemase at a Japanese hospital where FRI-4 carbapenemase was discovered

J Antimicrob Chemother. 2019 Nov 1;74(11):3390-3392. doi: 10.1093/jac/dkz336.

Authors

Yoshifumi Uwamino^{1

2}, Hiroaki Kubota³, Takashi Sasaki⁴, Asami Kosaka², Mie Furuhashi⁵, Shunsuke Uno², Jun Kudoh⁵, Mitsuru Murata¹, Naoki Hasegawa²

Affiliations

¹ Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan.
² Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
³ Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
⁴ Center for Supercentenarian Medical Research, Keio University School of Medicine, Tokyo, Japan.
⁵ Laboratory of Gene Medicine, Keio University School of Medicine, Tokyo, Japan.

PMID: 31377813
DOI: 10.1093/jac/dkz336

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Amino Acid Sequence
Anti-Bacterial Agents / pharmacology
Bacterial Proteins / genetics*
Drug Resistance, Multiple, Bacterial / genetics*
Enterobacter cloacae / drug effects
Enterobacter cloacae / enzymology*
Enterobacter cloacae / genetics
Enterobacter cloacae / isolation & purification*
Enterobacteriaceae Infections / microbiology
Feces / microbiology
Hospitals
Humans
Japan
Microbial Sensitivity Tests
Retrospective Studies
beta-Lactamases / genetics*

Substances

Anti-Bacterial Agents
Bacterial Proteins
beta-Lactamases
carbapenemase